Effect of initial combination therapy with sitagliptin, a dipeptidyl peptidase-4 inhibitor, and pioglitazone on glycemic control and measures of β-cell function in patients with type 2 diabetes. (Q51381776)
Jump to navigation
Jump to search
scientific article published in February 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Effect of initial combination therapy with sitagliptin, a dipeptidyl peptidase-4 inhibitor, and pioglitazone on glycemic control and measures of β-cell function in patients with type 2 diabetes. |
scientific article published in February 2011 |
Statements
1 reference
Effect of initial combination therapy with sitagliptin, a dipeptidyl peptidase-4 inhibitor, and pioglitazone on glycemic control and measures of β-cell function in patients with type 2 diabetes. (English)
1 reference
K H Yoon
1 reference
G R Shockey
1 reference
R Teng
1 reference
G T Golm
1 reference
P R Thakkar
1 reference
A G Meehan
1 reference
D E Williams-Herman
1 reference
K D Kaufman
1 reference
J M Amatruda
1 reference
H Steinberg
1 reference
1 February 2011
1 reference
65
1 reference
2
1 reference
154-164
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference